Pfizer (NYSE:PFE) Stock Analyst Ratings

Pfizer (NYSE:PFE) Stock Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/23/2024 30.03% Guggenheim → $36 Initiates Coverage On → Buy
01/31/2024 62.54% Cantor Fitzgerald → $45 Reiterates Overweight → Overweight
01/09/2024 62.54% Cantor Fitzgerald → $45 Reiterates Overweight → Overweight
01/04/2024 15.59% TD Cowen → $32 Downgrades Outperform → Market Perform
12/14/2023 30.03% Truist Securities $42 → $36 Maintains Buy
12/14/2023 -2.47% UBS $34 → $27 Maintains Neutral
12/14/2023 1.14% Barclays $34 → $28 Maintains Equal-Weight
12/04/2023 51.71% Truist Securities → $42 Reiterates Buy → Buy
11/20/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
11/01/2023 22.81% Barclays $35 → $34 Maintains Equal-Weight
11/01/2023 33.65% Morgan Stanley $39 → $37 Maintains Equal-Weight
10/20/2023 22.81% UBS $36 → $34 Assumes Neutral → Neutral
10/17/2023 51.71% Truist Securities $62 → $42 Maintains Buy
10/17/2023 40.87% Morgan Stanley $40 → $39 Maintains Equal-Weight
10/17/2023 26.42% Wells Fargo $39 → $35 Maintains Equal-Weight
10/16/2023 19.2% BMO Capital $44 → $33 Maintains Outperform
10/16/2023 26.42% Citigroup $42 → $35 Maintains Neutral
10/16/2023 22.81% JP Morgan $36 → $34 Maintains Neutral
10/16/2023 26.42% Wells Fargo $39 → $35 Maintains Equal-Weight
10/16/2023 40.87% Jefferies $38 → $39 Upgrades Hold → Buy
10/06/2023 30.03% JP Morgan $39 → $36 Maintains Neutral
10/02/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
09/18/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
09/13/2023 123.95% Truist Securities → $62 Reiterates Buy → Buy
09/05/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/30/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/22/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
08/02/2023 123.95% Truist Securities $64 → $62 Maintains Buy
08/02/2023 44.48% Morgan Stanley $42 → $40 Maintains Equal-Weight
08/02/2023 58.93% BMO Capital $45 → $44 Maintains Outperform
07/21/2023 51.71% Morgan Stanley $43 → $42 Maintains Equal-Weight
07/14/2023 80.6% HSBC → $50 Initiates Coverage On → Buy
07/11/2023 55.32% Morgan Stanley $43 → $43 Reiterates Equal-Weight → Equal-Weight
07/11/2023 37.26% Barclays $40 → $38 Maintains Equal-Weight
06/29/2023 44.48% Credit Suisse $47 → $40 Downgrades Outperform → Neutral
06/23/2023 170.9% Cantor Fitzgerald $75 → $75 Reiterates Overweight → Overweight
06/22/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
05/17/2023 170.9% Cantor Fitzgerald → $75 Reiterates Overweight → Overweight
05/11/2023 37.26% Daiwa Capital → $38 Downgrades Outperform → Neutral
05/03/2023 69.77% Credit Suisse $50 → $47 Maintains Outperform
05/03/2023 44.48% Barclays $43 → $40 Maintains Equal-Weight
04/21/2023 62.54% B of A Securities $50 → $45 Maintains Neutral
04/12/2023 55.32% Barclays $44 → $43 Maintains Equal-Weight
04/10/2023 58.93% Morgan Stanley $45 → $44 Maintains Equal-Weight
03/17/2023 58.93% Wells Fargo $50 → $44 Maintains Equal-Weight
03/06/2023 55.32% Jefferies → $43 Initiates Coverage On → Hold
02/07/2023 84.22% Daiwa Capital → $51 Upgrades Neutral → Outperform
02/01/2023 62.54% Morgan Stanley $53 → $45 Maintains Equal-Weight
02/01/2023 170.9% Cantor Fitzgerald → $75 Reiterates → Overweight
02/01/2023 80.6% Credit Suisse $54 → $50 Maintains Outperform
02/01/2023 91.44% BMO Capital $55 → $53 Maintains Outperform
02/01/2023 58.93% Barclays $49 → $44 Maintains Equal-Weight
02/01/2023 66.15% Atlantic Equities $50 → $46 Maintains Neutral
02/01/2023 73.38% SVB Leerink $49 → $48 Maintains Market Perform
01/26/2023 69.77% UBS $55 → $47 Downgrades Buy → Neutral
01/17/2023 80.6% Wells Fargo $54 → $50 Downgrades Overweight → Equal-Weight
01/04/2023 116.72% B of A Securities → $60 Downgrades Buy → Neutral
12/14/2022 91.44% Morgan Stanley $51 → $53 Maintains Equal-Weight
12/13/2022 116.72% Goldman Sachs $47 → $60 Upgrades Neutral → Buy
11/18/2022 98.66% Credit Suisse → $55 Initiates Coverage On → Outperform
11/03/2022 76.99% SVB Leerink $48 → $49 Maintains Market Perform
11/02/2022 95.05% Wells Fargo $55 → $54 Maintains Overweight
11/02/2022 76.99% Barclays $44 → $49 Maintains Equal-Weight
11/02/2022 84.22% Morgan Stanley $50 → $51 Maintains Equal-Weight
10/12/2022 80.6% Morgan Stanley $49 → $50 Maintains Equal-Weight
10/12/2022 58.93% Barclays $50 → $44 Maintains Equal-Weight
10/11/2022 73.38% SVB Leerink $53 → $48 Maintains Market Perform
08/01/2022 87.83% Barclays $50 → $52 Maintains Equal-Weight
07/29/2022 91.44% SVB Leerink $55 → $53 Maintains Market Perform
07/08/2022 76.99% Morgan Stanley $52 → $49 Maintains Equal-Weight
05/04/2022 87.83% Morgan Stanley $55 → $52 Maintains Equal-Weight
05/04/2022 98.66% Wells Fargo $60 → $55 Maintains Overweight
04/05/2022 105.89% Citigroup $46 → $57 Maintains Neutral
02/10/2022 98.66% Morgan Stanley $60 → $55 Maintains Equal-Weight
01/07/2022 134.78% Wells Fargo $60 → $65 Maintains Overweight
01/05/2022 152.84% B of A Securities $59 → $70 Upgrades Neutral → Buy
12/17/2021 84.22% Goldman Sachs → $51 Initiates Coverage On → Neutral
12/15/2021 102.28% SVB Leerink $52 → $56 Maintains Market Perform
12/14/2021 102.28% Mizuho $44 → $56 Maintains Neutral
12/13/2021 116.72% UBS $52 → $60 Upgrades Neutral → Buy
12/10/2021 95.05% Barclays $44 → $54 Maintains Equal-Weight
12/09/2021 116.72% Wells Fargo → $60 Initiates Coverage On → Overweight
11/29/2021 116.72% Morgan Stanley $50 → $60 Maintains Equal-Weight
11/19/2021 116.72% BMO Capital → $60 Initiates Coverage On → Outperform
11/03/2021 73.38% SVB Leerink $50 → $48 Maintains Market Perform
10/12/2021 73.38% Morgan Stanley $45 → $48 Maintains Equal-Weight
09/20/2021 80.6% SVB Leerink $49 → $50 Maintains Market Perform
07/30/2021 55.32% Mizuho $42 → $43 Maintains Neutral
07/29/2021 62.54% Morgan Stanley $42 → $45 Maintains Equal-Weight
07/29/2021 76.99% SVB Leerink $47 → $49 Maintains Market Perform
06/17/2021 58.93% RBC Capital $43 → $44 Maintains Sector Perform
05/10/2021 51.71% Morgan Stanley $38 → $42 Maintains Equal-Weight
05/06/2021 51.71% Mizuho → $42 Downgrades Buy → Neutral
05/05/2021 55.32% SVB Leerink $39 → $43 Maintains Market Perform
03/26/2021 40.87% SVB Leerink $40 → $39 Maintains Market Perform
02/04/2021 48.09% DZ Bank → $41 Upgrades Hold → Buy
02/03/2021 44.48% SVB Leerink $44 → $40 Maintains Market Perform
02/03/2021 51.71% Mizuho $44 → $42 Maintains Buy
01/29/2021 37.26% Morgan Stanley $40 → $38 Maintains Equal-Weight
12/16/2020 51.71% RBC Capital $43 → $42 Downgrades Outperform → Sector Perform
11/19/2020 44.48% Goldman Sachs → $40 Reinstates → Neutral
11/10/2020 51.71% Bernstein → $42 Initiates Coverage On → Market Perform
10/28/2020 55.32% SVB Leerink $42 → $43 Maintains Market Perform
10/23/2020 51.71% Truist Securities → $42 Initiates Coverage On → Buy
10/12/2020 40.87% Atlantic Equities $44 → $39 Downgrades Overweight → Neutral
09/29/2020 37.26% Berenberg → $38 Initiates Coverage On → Hold
07/30/2020 51.71% Morgan Stanley $36 → $42 Maintains Equal-Weight
07/29/2020 40.87% UBS $37 → $39 Maintains Neutral
07/29/2020 51.71% SVB Leerink $39 → $42 Maintains Market Perform
06/16/2020 44.48% SVB Leerink → $40 Initiates Coverage On → Market Perform
06/01/2020 30.03% JP Morgan $37 → $36 Maintains Neutral
04/29/2020 33.65% Barclays $36 → $37 Maintains Equal-Weight
04/02/2020 30.03% Morgan Stanley $43 → $36 Maintains Equal-Weight
03/27/2020 58.93% RBC Capital $46 → $44 Maintains Outperform
02/27/2020 30.03% Barclays → $36 Initiates Coverage On → Equal-Weight
02/06/2020 51.71% Mizuho → $42 Initiates Coverage On → Buy
01/07/2020 66.15% RBC Capital → $46 Initiates Coverage On → Outperform
10/17/2019 33.65% B of A Securities → $37 Reinstates → Neutral
08/28/2019 30.03% DZ Bank → $36 Upgrades Sell → Hold
08/27/2019 37.26% Morgan Stanley $40 → $38 Maintains Equal-Weight
07/30/2019 B of A Securities Downgrades Buy → Neutral
07/30/2019 Morgan Stanley Downgrades Overweight → Equal-Weight
06/04/2019 73.38% Morgan Stanley → $48 Reinstates → Overweight
04/01/2019 73.38% B of A Securities $45 → $48 Maintains Buy
Scroll to Top